• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖激酶的组织特异性表达:肝脏和胰岛中基因产物的鉴定。

Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets.

作者信息

Iynedjian P B, Möbius G, Seitz H J, Wollheim C B, Renold A E

出版信息

Proc Natl Acad Sci U S A. 1986 Apr;83(7):1998-2001. doi: 10.1073/pnas.83.7.1998.

DOI:10.1073/pnas.83.7.1998
PMID:3515342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC323217/
Abstract

The tissue distribution of glucokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1) was examined by protein blotting analysis. Antibodies raised against rat liver glucokinase recognized a single protein subunit with an apparent Mr of 56,500 on nitrocellulose blots of cytosol protein from liver, separated by sodium dodecyl sulfate/polyacrylamide gel electrophoresis. A protein of identical electrophoretic mobility was detected by immunoblotting of cytosol protein from pancreatic islets. Hepatic glucokinase and the immunoreactive islet product bound to and were eluted from DEAE-cellulose at the same ionic strength. Glucokinase was displayed as a set of two spots with apparent pI values of 5.54 and 5.64 by immunoblotting after two-dimensional gel electrophoresis. The two isoforms appeared equally abundant in liver extract, whereas the component with a pI of 5.64 was predominant in islets. By quantitative immunoblotting, glucokinase was estimated to represent 0.1% of total cytosol protein in liver and 1/20th as much in islets. The glucokinase activity of both liver and islet cytosols was suppressed by the antibodies to hepatic glucokinase. Immunoblotting of cytosol protein from intestinal mucosa, exocrine pancreas, epididymal adipose tissue, kidney, brain, and spleen failed to reveal the glucokinase protein. Thus, significant expression of the glucokinase gene appears restricted to the liver and pancreatic islets.

摘要

通过蛋白质印迹分析检测了葡萄糖激酶(ATP:D-己糖6-磷酸转移酶,EC 2.7.1.1)的组织分布。用针对大鼠肝脏葡萄糖激酶产生的抗体在十二烷基硫酸钠/聚丙烯酰胺凝胶电泳分离的肝脏胞质溶胶蛋白的硝酸纤维素印迹上识别出一个表观分子量为56,500的单一蛋白质亚基。通过对胰岛胞质溶胶蛋白进行免疫印迹检测到一种具有相同电泳迁移率的蛋白质。肝脏葡萄糖激酶和免疫反应性胰岛产物在相同离子强度下与DEAE-纤维素结合并从其上洗脱。二维凝胶电泳后通过免疫印迹显示葡萄糖激酶为一组两个斑点,表观pI值分别为5.54和5.64。这两种同工型在肝脏提取物中似乎同样丰富,而pI为5.64的组分在胰岛中占主导地位。通过定量免疫印迹法估计,葡萄糖激酶在肝脏中占总胞质溶胶蛋白的0.1%,在胰岛中的含量为肝脏的1/20。肝脏和胰岛胞质溶胶的葡萄糖激酶活性均被抗肝脏葡萄糖激酶的抗体所抑制。对肠黏膜、外分泌胰腺、附睾脂肪组织、肾脏、大脑和脾脏的胞质溶胶蛋白进行免疫印迹未能检测到葡萄糖激酶蛋白。因此,葡萄糖激酶基因的显著表达似乎仅限于肝脏和胰岛。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/77c5ce9039f5/pnas00311-0043-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/d7bc447e5259/pnas00311-0042-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/598d1c246248/pnas00311-0042-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/5c0d1303d511/pnas00311-0042-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/a7463ecf9ea5/pnas00311-0043-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/086cb294d2a7/pnas00311-0043-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/17691c51d5db/pnas00311-0043-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/77c5ce9039f5/pnas00311-0043-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/d7bc447e5259/pnas00311-0042-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/598d1c246248/pnas00311-0042-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/5c0d1303d511/pnas00311-0042-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/a7463ecf9ea5/pnas00311-0043-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/086cb294d2a7/pnas00311-0043-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/17691c51d5db/pnas00311-0043-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82af/323217/77c5ce9039f5/pnas00311-0043-d.jpg

相似文献

1
Tissue-specific expression of glucokinase: identification of the gene product in liver and pancreatic islets.葡萄糖激酶的组织特异性表达:肝脏和胰岛中基因产物的鉴定。
Proc Natl Acad Sci U S A. 1986 Apr;83(7):1998-2001. doi: 10.1073/pnas.83.7.1998.
2
Differential expression and regulation of the glucokinase gene in liver and islets of Langerhans.肝脏和胰岛中葡萄糖激酶基因的差异表达与调控。
Proc Natl Acad Sci U S A. 1989 Oct;86(20):7838-42. doi: 10.1073/pnas.86.20.7838.
3
Chromatographic resolution and kinetic characterization of glucokinase from islets of Langerhans.胰岛中葡萄糖激酶的色谱分辨率及动力学特性
Proc Natl Acad Sci U S A. 1983 Jan;80(1):85-9. doi: 10.1073/pnas.80.1.85.
4
Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.大鼠胰岛细胞和白色脂肪细胞线粒体中的孔蛋白:格列美脲对己糖激酶结合的鉴定与调控
Arch Biochem Biophys. 1994 Jan;308(1):8-23. doi: 10.1006/abbi.1994.1002.
5
Hexokinase isoenzymes of RIN-m5F insulinoma cells. Expression of glucokinase gene in insulin-producing cells.RIN-m5F胰岛素瘤细胞的己糖激酶同工酶。葡萄糖激酶基因在胰岛素生成细胞中的表达。
Biochem J. 1987 Jan 1;241(1):249-55. doi: 10.1042/bj2410249.
6
Effects of alternate RNA splicing on glucokinase isoform activities in the pancreatic islet, liver, and pituitary.可变RNA剪接对胰岛、肝脏和垂体中葡萄糖激酶同工型活性的影响。
J Biol Chem. 1991 Apr 15;266(11):6999-7007.
7
Regulation of glucokinase by a fructose-1-phosphate-sensitive protein in pancreatic islets.胰腺胰岛中一种对1-磷酸果糖敏感的蛋白质对葡萄糖激酶的调节作用。
Eur J Biochem. 1990 Jul 5;190(3):539-45. doi: 10.1111/j.1432-1033.1990.tb15607.x.
8
Human glucokinase gene: isolation, structural characterization, and identification of a microsatellite repeat polymorphism.人类葡萄糖激酶基因:分离、结构特征及微卫星重复多态性的鉴定。
Mol Endocrinol. 1992 Jul;6(7):1070-81. doi: 10.1210/mend.6.7.1354840.
9
Apparent 'glucokinase' activity in non-hepatic tissues due to N-acetyl-D-glucosamine kinase.由于N-乙酰-D-葡萄糖胺激酶,非肝脏组织中出现的“葡萄糖激酶”活性。
Biochim Biophys Acta. 1980 Aug 7;614(2):357-66. doi: 10.1016/0005-2744(80)90225-9.
10
Glucokinase gene structure. Functional implications of molecular genetic studies.葡萄糖激酶基因结构。分子遗传学研究的功能意义。
Diabetes. 1990 May;39(5):523-7. doi: 10.2337/diab.39.5.523.

引用本文的文献

1
Therapeutic management of PI3Kα inhibitor-induced hyperglycemia with a novel glucokinase activator: Advancing the Frontier of PI3Kα inhibitor therapy.使用新型葡萄糖激酶激活剂对PI3Kα抑制剂诱导的高血糖进行治疗管理:推进PI3Kα抑制剂治疗的前沿进展。
Mol Metab. 2025 Jun;96:102151. doi: 10.1016/j.molmet.2025.102151. Epub 2025 Apr 14.
2
Recent drug development of dorzagliatin, a new glucokinase activator, with the potential to treat Type 2 diabetes: A review study.新型葡萄糖激酶激活剂多格列艾汀的药物研发进展:一项综述研究。
J Diabetes. 2024 Jun;16(6):e13563. doi: 10.1111/1753-0407.13563.
3
Citrullination of glucokinase is linked to autoimmune diabetes.

本文引用的文献

1
CONCENTRATION OF AMINO ACIDS IN RAT MUSCLE AND PLASMA.大鼠肌肉和血浆中氨基酸的浓度
Nature. 1964 May 9;202:603-4. doi: 10.1038/202603a0.
2
Studies on glucose phosphorylation in rat liver.大鼠肝脏中葡萄糖磷酸化的研究。
Biochemistry. 1962 May 25;1:455-62. doi: 10.1021/bi00909a014.
3
A dot-immunobinding assay for monoclonal and other antibodies.一种用于单克隆抗体及其他抗体的斑点免疫结合测定法。
葡萄糖激酶的瓜氨酸化与自身免疫性糖尿病有关。
Nat Commun. 2022 Apr 6;13(1):1870. doi: 10.1038/s41467-022-29512-0.
4
Disruptions in hepatic glucose metabolism are involved in the diminished efficacy after chronic treatment with glucokinase activator.肝葡萄糖代谢紊乱与葡萄糖激酶激活剂长期治疗后疗效降低有关。
PLoS One. 2022 Mar 21;17(3):e0265761. doi: 10.1371/journal.pone.0265761. eCollection 2022.
5
Glucokinase as an emerging anti-diabetes target and recent progress in the development of its agonists.葡萄糖激酶作为一个新兴的抗糖尿病靶点及其激动剂的研发进展。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):606-615. doi: 10.1080/14756366.2021.2025362.
6
Molecular mechanisms of transcription factor mediated cell reprogramming: conversion of liver to pancreas.转录因子介导的细胞重编程的分子机制:肝脏向胰腺的转化。
Biochem Soc Trans. 2021 Apr 30;49(2):579-590. doi: 10.1042/BST20200219.
7
When a Little Bit More Makes the Difference: Expression Levels of GKRP Determines the Subcellular Localization of GK in Tanycytes.量变产生质变:GKRP的表达水平决定了GK在伸长细胞中的亚细胞定位。
Front Neurosci. 2019 Mar 29;13:275. doi: 10.3389/fnins.2019.00275. eCollection 2019.
8
The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism.先天性高胰岛素血症的遗传和分子机制
Front Endocrinol (Lausanne). 2019 Feb 26;10:111. doi: 10.3389/fendo.2019.00111. eCollection 2019.
9
Roles of Vitamin A Metabolism in the Development of Hepatic Insulin Resistance.维生素A代谢在肝脏胰岛素抵抗发生发展中的作用
ISRN Hepatol. 2013 Sep 30;2013:534972. doi: 10.1155/2013/534972. eCollection 2013.
10
Acetylation of glucokinase regulatory protein decreases glucose metabolism by suppressing glucokinase activity.葡萄糖激酶调节蛋白的乙酰化通过抑制葡萄糖激酶活性降低葡萄糖代谢。
Sci Rep. 2015 Dec 1;5:17395. doi: 10.1038/srep17395.
Anal Biochem. 1982 Jan 1;119(1):142-7. doi: 10.1016/0003-2697(82)90677-7.
4
New perspectives on pancreatic islet glucokinase.胰腺胰岛葡萄糖激酶的新视角
Am J Physiol. 1984 Jan;246(1 Pt 1):E1-13. doi: 10.1152/ajpendo.1984.246.1.E1.
5
Chromatographic resolution and kinetic characterization of glucokinase from islets of Langerhans.胰岛中葡萄糖激酶的色谱分辨率及动力学特性
Proc Natl Acad Sci U S A. 1983 Jan;80(1):85-9. doi: 10.1073/pnas.80.1.85.
6
Gluconeogenesis and related aspects of glycolysis.糖异生作用及糖酵解的相关方面。
Annu Rev Biochem. 1983;52:617-53. doi: 10.1146/annurev.bi.52.070183.003153.
7
Identification and significance of glucokinase in transplantable insulinomas.可移植性胰岛素瘤中葡萄糖激酶的鉴定及其意义
J Biol Chem. 1983 Feb 25;258(4):2094-7.
8
Regulation of glucose metabolism in pancreatic islets.胰岛中葡萄糖代谢的调节
Diabetes. 1981 Nov;30(11):911-22. doi: 10.2337/diab.30.11.911.
9
Apparent 'glucokinase' activity in non-hepatic tissues due to N-acetyl-D-glucosamine kinase.由于N-乙酰-D-葡萄糖胺激酶,非肝脏组织中出现的“葡萄糖激酶”活性。
Biochim Biophys Acta. 1980 Aug 7;614(2):357-66. doi: 10.1016/0005-2744(80)90225-9.
10
The identification of extrahepatic "glucokinase" as N-acetylglucosamine kinase.将肝外“葡萄糖激酶”鉴定为N-乙酰葡糖胺激酶。
J Biol Chem. 1980 Apr 10;255(7):2633-6.